Industry

Opdivo in combination with chemotherapy and Opdivo plus Yervoy® (ipilimumab) approved based on a Phase 3 trial showing improved overall survival versus chemotherapy alone1,2 Opdivo-based treatments are now approved for five indications in upper gastroesophageal cancers1 PRINCETON, N.J.–(BUSINESS WIRE)–$BMY #CheckMate—Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has … [Read more…]

In Recognition of Mental Health Awareness Month, Report Highlights Eight Findings on How Depression is Linked to Oral Health BOSTON–(BUSINESS WIRE)–CareQuest Institute for Oral Health® — a leading national nonprofit focused on creating a more accessible, equitable, and integrated oral health system — released a new report during Mental Health Awareness Month that spotlights the … [Read more…]

NEW YORK–(BUSINESS WIRE)–Viveon Health Acquisition Corp. (NYSE: “VHAQU” or the “Company”) announces that on May 24, 2022, as a result of its inability to timely file with the Securities and Exchange Commission (“SEC”) its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2022 (the “Form 10-Q”), it received a notice from … [Read more…]

SAN DIEGO–(BUSINESS WIRE)–Ambrx Biopharma Inc., or Ambrx, (NYSE: AMAM), a clinical stage biopharmaceutical company using an expanded genetic code technology platform to create Engineered Precision Biologics (EPBs), today announced that Feng Tian, Ph.D., Chairman of the Board, President and CEO of Ambrx, will participate in two upcoming investor conferences in June. Cowen’s 3rd Annual Oncology … [Read more…]

CHICAGO–(BUSINESS WIRE)–Exicure, Inc. (NASDAQ: XCUR), an early-stage biotechnology company focused on the development of next generation nucleic acid therapies targeting RNA to address both genetic and non-genetic neurological disorders and hair loss disorders, today announced that the Company’s Annual Meeting of Stockholders (the “Annual Meeting”) held in virtual format on Friday, May 27, 2022 at … [Read more…]

ST. JOSEPH & RIVERSIDE, Mo. & OVERLAND PARK, Kan.–(BUSINESS WIRE)–Epiphany Dermatology and the Colorado Melanoma Foundation are hitting the road this spring to provide FREE skin cancer screenings and sun-safety education to individuals throughout the Midwest, stopping in St. Joseph, MO 6/7, Riverside, MO 6/8, and Overland Park, KS 6/9. Since its inception, Epiphany Dermatology … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Clinical Laboratory Services – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global Clinical Laboratory Services Market to Reach $303.1 Billion by 2026 Amid the COVID-19 crisis, the global market for Clinical Laboratory Services estimated at US$222.7 Billion in the year 2020, is projected to reach a revised size … [Read more…]

Doctors with Cancer Treatment Centers of America, part of City of Hope, will also share innovative research LOS ANGELES–(BUSINESS WIRE)–#asco2022–City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced it would present research on promising treatments for bladder and blood cancers, as well as studies on precision … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Deep Brain Stimulation Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. The study assesses the current market status and innovations in DBS technologies. Considering the overall DBS market trend toward precision, personalized, and remote care, the report highlights the top 3 growth opportunities in the space for medical device and technology … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Oral Solid Dosage Excipients Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. The report analysis of the oral solid dosage excipients market aims at quantifying the consumption and analyzing the impact of key disruptive, transformative, and competitive trends across the value chain to present a forecast from 2022 to 2030. The … [Read more…]